Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. / Gislason, Gunnar H; Abildstrom, Steen Z; Rasmussen, Jeppe Nørgaard; Rasmussen, Søren; Buch, Pernille; Gustafsson, Ida; Friberg, Jens; Gadsbøll, Niels; Køber, Lars; Stender, Steen; Madsen, Mette; Torp-Pedersen, Christian.

I: Scandinavian Cardiovascular Journal, Bind 39, Nr. 1-2, 2005, s. 42-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

Gislason, GH, Abildstrom, SZ, Rasmussen, JN, Rasmussen, S, Buch, P, Gustafsson, I, Friberg, J, Gadsbøll, N, Køber, L, Stender, S, Madsen, M & Torp-Pedersen, C 2005, 'Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002.', Scandinavian Cardiovascular Journal, bind 39, nr. 1-2, s. 42-9.

APA

Gislason, G. H., Abildstrom, S. Z., Rasmussen, J. N., Rasmussen, S., Buch, P., Gustafsson, I., Friberg, J., Gadsbøll, N., Køber, L., Stender, S., Madsen, M., & Torp-Pedersen, C. (2005). Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. Scandinavian Cardiovascular Journal, 39(1-2), 42-9.

Vancouver

Gislason GH, Abildstrom SZ, Rasmussen JN, Rasmussen S, Buch P, Gustafsson I o.a. Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. Scandinavian Cardiovascular Journal. 2005;39(1-2):42-9.

Author

Gislason, Gunnar H ; Abildstrom, Steen Z ; Rasmussen, Jeppe Nørgaard ; Rasmussen, Søren ; Buch, Pernille ; Gustafsson, Ida ; Friberg, Jens ; Gadsbøll, Niels ; Køber, Lars ; Stender, Steen ; Madsen, Mette ; Torp-Pedersen, Christian. / Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. I: Scandinavian Cardiovascular Journal. 2005 ; Bind 39, Nr. 1-2. s. 42-9.

Bibtex

@article{96e80d10001b11ddbee902004c4f4f50,
title = "Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002.",
abstract = "OBJECTIVES: To study the use of beta-blockers and angiotensin-converting enzyme (ACE) inhibitors after acute myocardial infarction (AMI) in Denmark from 1995 to 2002. DESIGN: Information about patients with first AMI aged > or = 30 years and the dispensing of beta-blockers and ACE inhibitors from pharmacies within 30 d from discharge was obtained from the National Patient Registry and the Danish Registry of Medicinal Product Statistics. RESULTS: Beta-blocker use increased from 38.1% of patients in 1995 to 67.9% in 2002 (OR = 3.85, CI: 3.58-4.13). Women, elderly patients and patients taking loop-diuretics and antidiabetic drugs received beta-blockers less frequently, but patients taking loop-diuretics or antidiabetic drugs had the greatest increase. ACE inhibitor use increased from 24.5 to 35.5% (OR = 1.86, CI: 1.72-2.01). Women, patients aged < 60 years or > or = 80 years and patients not taking loop-diuretics received ACE inhibitors less frequently, but patients not taking loop-diuretics had the greatest increase. CONCLUSIONS: Beta-blocker use increased markedly post-AMI from 1995 to 2002, whereas ACE inhibitor use increased modestly. The results suggested undertreatment of women, elderly patients and people with diabetes. Udgivelsesdato: 2005-Apr",
author = "Gislason, {Gunnar H} and Abildstrom, {Steen Z} and Rasmussen, {Jeppe N{\o}rgaard} and S{\o}ren Rasmussen and Pernille Buch and Ida Gustafsson and Jens Friberg and Niels Gadsb{\o}ll and Lars K{\o}ber and Steen Stender and Mette Madsen and Christian Torp-Pedersen",
note = "Keywords: Adrenergic beta-Antagonists; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Denmark; Drug Utilization; Female; Follow-Up Studies; Health Care Surveys; Humans; Incidence; Male; Myocardial Infarction; Odds Ratio; Physician's Practice Patterns; Probability; Registries; Sensitivity and Specificity; Severity of Illness Index; Sex Factors; Survival Rate",
year = "2005",
language = "English",
volume = "39",
pages = "42--9",
journal = "Scandinavian Cardiovascular Journal",
issn = "1401-7458",
publisher = "Taylor & Francis",
number = "1-2",

}

RIS

TY - JOUR

T1 - Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002.

AU - Gislason, Gunnar H

AU - Abildstrom, Steen Z

AU - Rasmussen, Jeppe Nørgaard

AU - Rasmussen, Søren

AU - Buch, Pernille

AU - Gustafsson, Ida

AU - Friberg, Jens

AU - Gadsbøll, Niels

AU - Køber, Lars

AU - Stender, Steen

AU - Madsen, Mette

AU - Torp-Pedersen, Christian

N1 - Keywords: Adrenergic beta-Antagonists; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Denmark; Drug Utilization; Female; Follow-Up Studies; Health Care Surveys; Humans; Incidence; Male; Myocardial Infarction; Odds Ratio; Physician's Practice Patterns; Probability; Registries; Sensitivity and Specificity; Severity of Illness Index; Sex Factors; Survival Rate

PY - 2005

Y1 - 2005

N2 - OBJECTIVES: To study the use of beta-blockers and angiotensin-converting enzyme (ACE) inhibitors after acute myocardial infarction (AMI) in Denmark from 1995 to 2002. DESIGN: Information about patients with first AMI aged > or = 30 years and the dispensing of beta-blockers and ACE inhibitors from pharmacies within 30 d from discharge was obtained from the National Patient Registry and the Danish Registry of Medicinal Product Statistics. RESULTS: Beta-blocker use increased from 38.1% of patients in 1995 to 67.9% in 2002 (OR = 3.85, CI: 3.58-4.13). Women, elderly patients and patients taking loop-diuretics and antidiabetic drugs received beta-blockers less frequently, but patients taking loop-diuretics or antidiabetic drugs had the greatest increase. ACE inhibitor use increased from 24.5 to 35.5% (OR = 1.86, CI: 1.72-2.01). Women, patients aged < 60 years or > or = 80 years and patients not taking loop-diuretics received ACE inhibitors less frequently, but patients not taking loop-diuretics had the greatest increase. CONCLUSIONS: Beta-blocker use increased markedly post-AMI from 1995 to 2002, whereas ACE inhibitor use increased modestly. The results suggested undertreatment of women, elderly patients and people with diabetes. Udgivelsesdato: 2005-Apr

AB - OBJECTIVES: To study the use of beta-blockers and angiotensin-converting enzyme (ACE) inhibitors after acute myocardial infarction (AMI) in Denmark from 1995 to 2002. DESIGN: Information about patients with first AMI aged > or = 30 years and the dispensing of beta-blockers and ACE inhibitors from pharmacies within 30 d from discharge was obtained from the National Patient Registry and the Danish Registry of Medicinal Product Statistics. RESULTS: Beta-blocker use increased from 38.1% of patients in 1995 to 67.9% in 2002 (OR = 3.85, CI: 3.58-4.13). Women, elderly patients and patients taking loop-diuretics and antidiabetic drugs received beta-blockers less frequently, but patients taking loop-diuretics or antidiabetic drugs had the greatest increase. ACE inhibitor use increased from 24.5 to 35.5% (OR = 1.86, CI: 1.72-2.01). Women, patients aged < 60 years or > or = 80 years and patients not taking loop-diuretics received ACE inhibitors less frequently, but patients not taking loop-diuretics had the greatest increase. CONCLUSIONS: Beta-blocker use increased markedly post-AMI from 1995 to 2002, whereas ACE inhibitor use increased modestly. The results suggested undertreatment of women, elderly patients and people with diabetes. Udgivelsesdato: 2005-Apr

M3 - Journal article

C2 - 16097413

VL - 39

SP - 42

EP - 49

JO - Scandinavian Cardiovascular Journal

JF - Scandinavian Cardiovascular Journal

SN - 1401-7458

IS - 1-2

ER -

ID: 3439582